Fact vs Fallacy: The Anti-Vaccine Discussion Reloaded Lucas B. StolleRohit NalamasuThe NEMA Research Group Commentary Open access 23 September 2020 Pages: 4481 - 4490
The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence Brian G. FeaganMona MarabaniGilberto Castañeda-Hernández Review Open access 10 September 2020 Pages: 4491 - 4518
Mast Cells in Diabetes and Diabetic Wound Healing Jie DongLihong ChenAristidis Veves Review Open access 15 September 2020 Pages: 4519 - 4537
Single-Use (Disposable) Flexible Bronchoscopes: The Future of Bronchoscopy? Sarah P. BarronMarcus P. Kennedy Review Open access 17 September 2020 Pages: 4538 - 4548
Management of Dyslipidemia in Individuals with Low-to-Moderate Cardiovascular Risk: Role of Nutraceuticals Maryna Mykolaivna DolzhenkoOlga Yulianivna BarnettOlesia Vadymivna Zinych Review 26 September 2020 Pages: 4549 - 4567
Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease Rocío SalsosoTalia F. DalcoquioJose C. Nicolau Original Research Open access 05 September 2020 Pages: 4568 - 4584
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial Jin LiWeijian GuoShukui Qin Original Research 08 September 2020 Pages: 4585 - 4598
Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis Aki ShiozawaSari HopsonJohn Hairston Original Research Open access 10 September 2020 Pages: 4599 - 4613
Obesity Trends Amongst Hospitalized Patients with Spinal Cord Stimulator Implants Vwaire OrhurhuFaizan KhanThomas Simopoulos Original Research 15 September 2020 Pages: 4614 - 4626
A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease Igor V. MaevAlexey A. SamsonovKirill M. Starostin Original Research Open access 16 September 2020 Pages: 4627 - 4640
Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial Olivier BruyèreNadia DardenneJean-Yves Reginster Original Research Open access 21 September 2020 Pages: 4641 - 4648
Effectiveness of Atorvastatin in the Treatment of Asymptomatic Heart Failure After Myocardial Infarction: A Clinical Study Dong WangLong BaiJi-Dong Zhang Original Research 23 September 2020 Pages: 4649 - 4659
Bioequivalence Study Comparing Fixed-Dose Combination of Clopidogrel and Aspirin with Coadministration of Individual Formulations in Chinese Subjects Under Fed Conditions: A Phase I, Open-Label, Randomized, Crossover Study Yan LiJeffrey E. MingXinghe Wang Original Research Open access 24 September 2020 Pages: 4660 - 4674
Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function Angelo Maria MinnellaMartina MaceroniBenedetto Falsini Original Research Open access 24 September 2020 Pages: 4675 - 4684
A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive Lynn R. WebsterErik HansenThomas Smith Original Research Open access 25 September 2020 Pages: 4685 - 4696
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial Hoda TaheriMojtaba MalekMohammad E. Khamseh Original Research Open access 25 September 2020 Pages: 4697 - 4708
The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data Mark SulkowskiRaluca Ionescu-IttuYuri Sanchez-Gonzalez Brief Report Open access 14 September 2020 Pages: 4709 - 4719
Open-Label Assessment of the Effects of Itraconazole and Rifampicin on Balovaptan Pharmacokinetics in Healthy Volunteers Michael G. M. DerksChristoph WandelChristoph Meyenberg Brief Report 15 September 2020 Pages: 4720 - 4729
PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis Linda Stein GoldJavier Alonso-Llamazaresfor the PSO-LONG Trial Investigators Study Protocol Open access 23 September 2020 Pages: 4730 - 4753
Correction to: The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants Joseph ChenHuiping XuYazdi K. Pithavala Correction 10 September 2020 Pages: 4754 - 4754
Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis Pietro LamperticoStefan MaussSteven Flamm Correction Open access 11 September 2020 Pages: 4755 - 4756
Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review Mourad F. RezkBurkhard Pieper Correction Open access 11 September 2020 Pages: 4757 - 4757
Correction to: Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients Shuichi TsuruokaTakamasa EndoNaoto Hashimoto Correction Open access 15 September 2020 Pages: 4758 - 4764